Quest Diagnostics Inc: Stock Rating Summary
 Quest Diagnostics Inc, a large-cap growth company in the health care sector, is expected to outperform the market over the next six months with very low risk. 10 is the best possible rating.
- Pro
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The StockScouter measure of relative price change and consistency is very high. Very positive
- Con
- Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a large company like DGX
- The ratio of DGX's price-to-earnings multiple to its five-year growth rate is above the average of all stocks in the StockScouter universe. Negative
Learn more about the StockScouter rating system.
|
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that growth stocks will be neutral, large-cap stocks will be neutral, and health care stocks will be neutral. More on market trends
advertisement
| Previous Ratings |
|---|
| 1 Month ago | 9 |
| 3 Months ago | 8 |
| 6 Months ago | N/A |
|
Page generated 11/24/2009 10:24 PM Eastern Time
Recent News
